Accelerator Life Science Partners

General contacts
Investor type

VC

Founded

2003

AUM

-

Location

Seattle, Washington, United States

Investment Ticket

$1-5 m

Investment Stage

Series A Seed Late Stage (Series C+)

Region of investment

North America Asia
Investor profile last updated: 18 August, 2026

Profile

Accelerator Life Science Partners is a venture capital firm based in Seattle, Washington, founded in 2003. The firm is led by experienced professionals including Senior Managing Director Thong Q. Le, Managing Director Kendall Mohler, Ph.D., and Managing Director Ian A.W. Howes. They focus on building successful biotechnology companies by providing a comprehensive toolkit of business, scientific, and financial resources.

The firm invests primarily in the biotechnology, life sciences, and healthcare sectors, supporting companies from early-stage to later-stage development. They are known for their hands-on approach and strategic partnerships with top-tier investors and research institutions. Accelerator Life Science Partners does not publicly disclose specific check sizes or total assets under management.

Notable investments include KayoThera - drug discovery, Proniras - drug discovery, Automera - drug discovery, Magnolia Neurosciences - drug discovery, and Rodeo Therapeutics - drug discovery. These companies highlight the firm's focus on advancing innovative solutions in the life sciences sector.

Industry

HealthTech Life Sciences MedTech Fintech Financial Services Pharmaceuticals Biotechnology

Contacts

Name
Title
Email
Social Networks
avatar
Thong Q. Le Senior Managing Director & Chairman
Senior Managing Director & Chairman
t•••@•••
LinkedIn
avatar
Alice Chen, PhD Partner , Head of APAC
Partner , Head of APAC
a•••@•••
LinkedIn
Upgrade to see contacts
avatar
QyoAqjLMaE21ZD34 QyoAqjLMaE21ZD34
QyoAqjLMaE21ZD34
[email protected]
linkedin twitter
avatar
QyoAqjLMaE21ZD34 QyoAqjLMaE21ZD34
QyoAqjLMaE21ZD34
[email protected]
linkedin twitter
avatar
QyoAqjLMaE21ZD34 QyoAqjLMaE21ZD34
QyoAqjLMaE21ZD34
[email protected]
linkedin twitter
Investment-team contacts for Accelerator Life Science Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Accelerator Life Science Partners

Accelerator Life Science Partners is a venture capital firm. It backs companies at Series A, Seed and Late Stage (Series C+), writing tickets of $1-5 m.
Accelerator Life Science Partners is located in Seattle, Washington, United States.
Accelerator Life Science Partners was founded in 2003.
Accelerator Life Science Partners invests in companies and startups in HealthTech, Life Sciences, MedTech, Fintech, Financial Services, Pharmaceuticals, Biotechnology.
Accelerator Life Science Partners invests in companies and startups in North America, Asia.
Accelerator Life Science Partners invests in companies and startups at Series A, Seed, Late Stage (Series C+).
Accelerator Life Science Partners usually invests $1-5 m on average.
Accelerator Life Science Partners can be reached through its website acceleratorlsp.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Accelerator Life Science Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Accelerator Life Science Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 18 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.